Literature DB >> 35333670

The Cognition/Metacognition Trade-Off.

David Rosenbaum1, Moshe Glickman2,3, Stephen M Fleming2,3,4, Marius Usher1.   

Abstract

Integration to boundary is an optimal decision algorithm that accumulates evidence until the posterior reaches a decision boundary, resulting in the fastest decisions for a target accuracy. Here, we demonstrated that this advantage incurs a cost in metacognitive accuracy (confidence), generating a cognition/metacognition trade-off. Using computational modeling, we found that integration to a fixed boundary results in less variability in evidence integration and thus reduces metacognitive accuracy, compared with a collapsing-boundary or a random-timer strategy. We examined how decision strategy affects metacognitive accuracy in three cross-domain experiments, in which 102 university students completed a free-response session (evidence terminated by the participant's response) and an interrogation session (fixed number of evidence samples controlled by the experimenter). In both sessions, participants observed a sequence of evidence and reported their choice and confidence. As predicted, the interrogation protocol (preventing integration to boundary) enhanced metacognitive accuracy. We also found that in the free-response sessions, participants integrated evidence to a collapsing boundary-a strategy that achieves an efficient compromise between optimizing choice and metacognitive accuracy.

Entities:  

Keywords:  computational models; decision confidence; decision-making; diffusion model; integration to boundary; judgment; metacognition; optimality; preregistered; reaction time

Mesh:

Year:  2022        PMID: 35333670     DOI: 10.1177/09567976211043428

Source DB:  PubMed          Journal:  Psychol Sci        ISSN: 0956-7976


  1 in total

1.  Relating psychiatric symptoms and self-regulation during the COVID-19 crisis.

Authors:  Matilde M Vaghi; McKenzie P Hagen; Henry M Jones; Jeanette A Mumford; Patrick G Bissett; Russell A Poldrack
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.